secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001193125-25-005050
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx CFO Karsten Voermann resigns; CAO Romin Nabiey named interim CFO
-----------------------------------------------------------------------

- Karsten Voermann resigns as CFO effective Jan 17, 2025, for personal reasons, not due to any disagreement.
- Romin Nabiey, current Chief Accounting Officer, appointed Interim CFO and principal financial officer.
- Nabiey will continue as CAO; has been with GoodRx since 2017 in various finance roles.
- Voermann's vested stock options remain exercisable through Jan 17, 2026; he retains earned 2024 bonus.
- Company begins search for permanent CFO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000119312525005050/0001193125-25-005050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000119312525005050/d926337d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-005050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer